Bioceres Crop Solutions Corp. (BIOX)
Automate Your Wheel Strategy on BIOX
With Tiblio's Option Bot, you can configure your own wheel strategy including BIOX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BIOX
- Rev/Share 6.49
- Book/Share 5.5076
- PB 0.9604
- Debt/Equity 0.9231
- CurrentRatio 1.3286
- ROIC -0.0193
- MktCap 296622084.0
- FreeCF/Share -0.2853
- PFCF -16.547
- PE 115.6527
- Debt/Assets 0.342
- DivYield 0
- ROE 0.0082
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Bioceres Q3 2025 Illustrates The Financial Challenges And A Distressed Argentinian Market
Published: June 01, 2025 by: Seeking Alpha
Sentiment: Neutral
Bioceres faces mounting financial stress, with Argentina's weak agriculture sector and loss of Syngenta payments driving revenue and EBITDA declines. Cash flow is tightening rapidly; asset sales and one-off inventory benefits are masking underlying losses, while debt and interest costs loom large. Long-term product developments like HB4 and RINO offer potential, but have yet to deliver meaningful, scalable revenue or margin improvements.
Read More
Bioceres Crop Solutions Corp. (BIOX) Q3 2025 Earnings Call Transcript
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q3 2025 Results Conference Call May 21, 2025 8:30 AM ET Company Participants Paula Savanti - Head, Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Milen Marinov - Chief Commercial Officer Conference Call Participants Kristen Owen - Oppenheimer Ben Klieve - Lake Street Capital Markets Austin Moeller - Canaccord Steve Byrne - Bank of America Kemp Dolliver - Brookline Capital Markets Operator Hello, everyone, and thank you for joining us on today's Bioceres Crop Solutions Fiscal Third Quarter 2025 Financial and Operational Results. My name is Drew …
Read More
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Negative
Bioceres Crop (BIOX) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to earnings of $0.14 per share a year ago.
Read More
Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results
Published: May 21, 2025 by: Business Wire
Sentiment: Neutral
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.
Read More
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
Published: April 21, 2025 by: Accesswire
Sentiment: Neutral
LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together …
Read More
Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms
Published: April 21, 2025 by: Accesswire
Sentiment: Neutral
LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together …
Read More
Bioceres Is Approaching Distressed Prices, But I Remain On The Sidelines
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Negative
Bioceres Crop Solutions Corp. reported a disappointing Q2 2025 with revenues down 24%, driven by Argentina's economic crisis, despite improved international sales. BIOX stock is down 62% year-over-year, and I maintain a Hold rating due to concerns about the company's ability to turn around. The shift to a licensing model for HB4 technology and R&D cuts may improve short-term finances but pose long-term risks.
Read More
About Bioceres Crop Solutions Corp. (BIOX)
- IPO Date 2018-03-22
- Website https://biocerescrops.com
- Industry Agricultural Inputs
- CEO Dr. Federico Trucco Ph.D.
- Employees 400